This product is appropriately called a “GLP-1 receptor agonist analogue + GIP receptor agonist analogue with BPC-157.” GLP/GIP differs from GLP-1 alone in that it uses two receptors (GLP-1R and GIPR) instead of one in study data to ultimately help curb appetite, reduce gastric emptying, reduce the amount of food you eat and can help lower blood sugar. The addition of BPC-157 may have additional benefits associated with gut health as has been seen in BPC-157 based studies.